Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Gilead Sciences Inc buy gerihouse

Start price
€75.79
08.02.16 / 50%
Target price
€100.00
28.04.16
Performance (%)
14.98%
End price
€86.75
28.04.16
Summary
This prediction ended on 28.04.16 with a price of €86.75. The BUY prediction by gerihouse finished with a performance of 14.98%. gerihouse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Gilead Sciences Inc -2.279% -2.279% -18.655% 9.392%
iShares Core DAX® -0.552% 3.281% 15.052% 17.017%
iShares Nasdaq 100 -1.415% 4.535% 26.243% 54.337%
iShares Nikkei 225® -0.877% -1.739% 4.897% 4.751%
iShares S&P 500 -0.415% 3.239% 23.253% 46.758%

According to gerihouse what are the pros and cons of Gilead Sciences Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Future proof or reliable business model
Small cyclical dependencies
Cons

Comments by gerihouse for this prediction

In the thread Gilead Sciences Inc diskutieren
Prediction Buy
Perf. (%) 14.98%
Target price 100.000
Change
Ends at 28.04.16

Hier is alles super!

Gilead Sciences gibt Finanzergebnisse für viertes Quartal und Gesamtjahr 2015 bekannt

- Produktumsatz im vierten Quartal steigt im Jahresvergleich um 16 Prozent auf 8,4 Milliarden US-Dollar -

- Produktumsatz im Gesamtjahr 2015 steigt im Jahresvergleich um 31 Prozent auf 32,2 Milliarden US-Dollar -

- Nicht GAAP-konformer Gewinn je Aktie für das Gesamtjahr 2015 steigt im Jahresvergleich um 56 Prozent auf 12,61 US-Dollar


Das Unternehmen Gilead Sciences, Inc. (Nasdaq: GILD) hat heute
seine Geschäftsergebnisse für das vierte Quartal und das Gesamtjahr
2015 bekannt gegeben. Der Gesamtumsatz im vierten Quartal 2015 belief
sich auf 8,5 Milliarden US-Dollar, was im Vergleich zu 7,3 Milliarden
US-Dollar im vierten Quartal 2014 steht. Der Nettogewinn im vierten
Quartal 2015 betrug 4,7 Milliarden US-Dollar oder 3,18 US-Dollar je
verwässerte Aktie, was im Vergleich zu 3,5 Milliarden US-Dollar oder
2,18 US-Dollar je verwässerte Aktie im vierten Quartal 2014 steht. Der
nicht GAAP-konforme Nettogewinn für das vierte Quartal 2015 ohne
Berücksichtigung erwerbsbezogener Ausgaben, Aufwendungen für
aktienbasierte Vergütungen und sonstiger Kosten betrug 4,9 Milliarden
US-Dollar oder 3,32 US-Dollar je verwässerte Aktie, was im Vergleich zu
3,9 Milliarden US-Dollar oder 2,43 US-Dollar je verwässerte Aktie für
das vierte Quartal 2014 steht.

Der Gesamtumsatz im Jahr
2015 belief sich auf 32,6 Milliarden US-Dollar gegenüber den 24,9
Milliarden US-Dollar im Jahr 2014. Der Nettogewinn für 2015 betrug
18,1 Milliarden US-Dollar oder 11,91 US-Dollar je verwässerte Aktie,
dies gegenüber 12,1 Milliarden US-Dollar oder 7,35 US-Dollar je
verwässerte Aktie für 2014. Der nicht GAAP-konforme Nettogewinn für
2015 ohne Berücksichtigung erwerbsbezogener Ausgaben, Aufwendungen für
aktienbasierte Vergütungen und sonstiger Kosten betrug 19,2
Milliarden US-Dollar oder 12,61 US-Dollar je verwässerte Aktie, was im
Vergleich zu 13,3 Milliarden US-Dollar oder 8,09 US-Dollar je
verwässerte Aktie für das Jahr 2014 steht.

Prediction Buy
Perf. (%) 14.98%
Target price 100.000
Change
Ends at 28.04.16

(Stop Loss Kurs erreicht)

Stopped prediction by gerihouse for Gilead Sciences Inc

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.87
08.06.20
€65.00
04.11.21
-18.67%
05.11.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.51
18.05.20
€90.00
30.05.20
-4.08%
30.05.20

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.59
02.05.20
€85.00
16.05.20
-8.49%
16.05.20

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€78.80
20.04.20
€85.00
02.05.20
-1.54%
02.05.20

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€68.19
28.02.20
€85.00
20.04.20
15.56%
20.04.20

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€57.14
28.10.19
€70.00
09.11.19
2.28%
09.11.19

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.55
16.09.19
€65.00
28.10.19
-4.05%
28.10.19

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.30
03.05.19
€70.00
27.05.19
1.57%
27.05.19

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€71.09
03.10.17
€76.00
25.06.18
-12.90%
25.06.18

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.60
21.06.17
€72.16
30.08.17
21.12%
30.08.17

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€80.73
29.04.16
€100.00
28.03.17
-20.63%
28.03.17

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€99.55
04.11.15
€115.00
29.01.16
-22.56%
29.01.16

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€88.52
12.10.15
€100.00
27.10.15
12.97%
27.10.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€86.75
24.08.15
€100.00
21.09.15
9.95%
21.09.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€93.74
04.05.15
€110.00
29.06.15
11.35%
29.06.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€85.69
05.02.15
€100.00
18.03.15
7.04%
18.03.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€81.88
08.09.14
€95.00
28.01.15
12.25%
28.01.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand